Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(28 sites)
United States
City of Hope National Medical Center, Duarte, California City of Hope at Irvine Lennar, Irvine, California Ronald Reagan UCLA Medical Center, Los Angeles, California UCLA Department of Medicine-Hematology/Oncology, Los Angeles, California Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica, California